Study #2023-0569
Chronic health conditions in down syndrome-associated acute leukemia: the down syndrome phenotyping acute leukemia study in survivors (DS-PALS survivors)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study attempts to learn more about the health of persons with Down syndrome after treatment for acute leukemia. Children with Down syndrome are at increased risk for side effects during treatment for acute leukemia, but it is unclear of their risk for long-term effects of cancer treatment. By learning more about the factors that may contribute to chronic health conditions and long-term effects after treatment for leukemia in persons with Down syndrome, clinical practice guidelines for survivorship care can be developed to help improve their quality-of-life.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
B Acute Lymphoblastic Leukemia Associated With Down Syndrome;Down Syndrome;Myeloid Leukemia Associated With Down Syndrome
Study phase:
Physician name:
Najat Daw Bitar
Department:
Pediatrics
For general questions about clinical trials:
1-844-227-7897
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.